Awarded contractRestrictedSuppliesPoland
Dostawa produktów leczniczych zawierających substancje Acalabrutinibum, Ravulizumabum oraz Trastuzumabum derutecan finansowanych w ramach Programów Lekowych
1 supplier awarded•1 lot awarded•€55,403 awarded
Buyer: Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie / Lublin, Poland
Published Jul 01, 2026Awarded May 14, 2026
Pharmaceutical products
Awarded value
€55.4K
Estimated value
€55.4K
Awarded at 100% of estimated value
Award date
May 14, 2026
Winners
1
Lots awarded
1
Winners
Astrazeneca Kft.
1 lotBudapeszt, HUN
€55,403 This contract
64 award notices•93 awarded lots•€82.34M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Astrazeneca Kft. | €55,403 | Pharmaceutical products (33600000) |